InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Host Jan. 19 Investor Webinar on Navigating Emerging Digital Health Trends

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that it will host an investor webinar on navigating emerging digital health trends in 2022. Interested parties are invited to join DarioHealth’s management and two renowned industry experts at 8 a.m. ET on Wednesday, Jan. 19, to better understand how strong tailwinds from the evolving digital health landscape are powering the company’s strategic approach for 2022. Sari Kaganoff, Rock Health’s general manager of consulting, brings deep experience advising companies on digital health strategy and innovation, sharing emerging trends shaping the digital health landscape. David Kaplan, former head of Mercer’s health care practice, specializes in the commercialization of digital health solutions, offering key insights on industry trends shaping opportunities in the employer, provider and payer markets. Finally, DarioHealth’s CEO Erez Raphael and its president and general manager for North America, Rick Anderson, will provide a deep dive into the company’s digital therapeutics platform, including a demonstration of the seamless user experience at the heart of user adoption. They will summarize the company’s 2021 major accomplishments and preview the strategic roadmap propelling DarioHealth to category leadership and sales activity in 2022.

To view the full press release, visit https://ibn.fm/Tx0IZ

About DarioHealth Corp.

DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market — covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario’s next-generation, AI-powered, digital therapeutic platform supports more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario’s unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. The company’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology and utilizes a performance-based approach to improve its users’ health. On the path to better health, Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.